Otsuka Holdings Co., Ltd. (OTSKF)
OTCMKTS
· Delayed Price · Currency is USD
49.50
0.00 (0.00%)
Jul 2, 2025, 4:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Pharmaceuticals | 1,629.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals Growth | 17.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutraceuticals | 557.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutraceuticals Growth | 11.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Products | 33.75B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Products Growth | -6.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment | 110.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Growth | 2.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 92.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -37.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals Segment Profit | 285.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals Segment Profit Growth | 114.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutraceuticals Segment Profit | 59.78B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutraceuticals Segment Profit Growth | 45.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Products Segment Profit | 23.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Products Segment Profit Growth | 67.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Profit | 7.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Profit Growth | -883.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eliminations from Segment Profit | -51.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eliminations from Segment Profit Growth | 14.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 92.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -37.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 92.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -37.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 699.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | 2.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America | 1,095.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | 25.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 242.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 10.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Others | 292.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Others Growth | 11.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Pharmaceuticals Business Profit | 390.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals Business Profit Growth | 46.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutraceuticals Business Profit | 64.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Nutraceuticals Business Profit Growth | -10.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Products Business Profit | 23.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Products Business Profit Growth | 10.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Business Profit | 6.95B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment Business Profit Growth | -7.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eliminations from Business Profit | -54.91B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eliminations from Business Profit Growth | 11.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|